SCHEMBL23558348

SCHEMBL23558348

O=C(O)CCc1ccc(C2=NC(c3ccc4c(c3)CCC(=O)N4)=NC2)cc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K8 P41279 1/20 0.39
▸ CYP11B1 P15538 4/20 0.38
▸ CYP11B2 P19099 4/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ PDE3B Q13370 2/20 0.38
▸ PDE3A Q14432 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ TBXAS1 P24557 1/20 0.38
▸ KIF11 P52732 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ MMP12 P39900 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25857002 0.79 MAPT (0.39) MAP3K8CYP11B1CYP11B2CYP1A2PDE3B
SCHEMBL11767335 0.69 MAOA (0.50) KIF11ALDH1A1NPC1CYP2D6HDAC3
SCHEMBL25856880 0.67 PGR (0.40) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL1294634 0.63 CA9 (0.39) MAP3K8CYP11B1CYP11B2KIF11POLB
SCHEMBL18648565 0.63 NPSR1 (0.56) POLBHDAC3HDAC4HDAC1HDAC2
SCHEMBL10595977 0.63 PDE3B (0.64) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL1294298 0.62 MAOB (0.50) NPC1MAOAMAOB
SCHEMBL3306566 0.62 KIF11 (0.69) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL11287532 0.62 MAOB (0.67) PDE3BPDE3AMAOAMAOB
SCHEMBL20425064 0.61 AKR1B1 (0.51) KIF11NPC1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 MAP3K8 1679/4885CYP11B1 1869/4885CYP11B2 2298/4885
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 MAP3K8 1679/4885CYP11B1 1869/4885CYP11B2 2298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback